360 High-Risk Vulnerability Immunization Tool V2.0 vs Halcyon Anti-Ransomware Platform: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Halcyon Anti-Ransomware Platform: Anti-ransomware platform with detection, prevention, recovery & 24/7 SOC. built by Halcyon. Core capabilities include Ransomware detection and prevention across attack chain stages, Data Exfiltration Protection (DXP) for early warning of data theft, Behavioral analysis engines trained on ransomware indicators..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Halcyon Anti-Ransomware Platform differentiates with Ransomware detection and prevention across attack chain stages, Data Exfiltration Protection (DXP) for early warning of data theft, Behavioral analysis engines trained on ransomware indicators.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Halcyon Anti-Ransomware Platform is developed by Halcyon. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Halcyon Anti-Ransomware Platform serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.